Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Advair Pediatric Once-Daily

ClinicalTrials.gov ID: NCT00920959

Public ClinicalTrials.gov record NCT00920959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 10:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Stratified, Randomized, Double-blind, Placebo-controlled, Parallel-group, 12 Week Trial Evaluating the Safety and Efficacy of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg Once Daily Versus Fluticasone Propionate DISKUS 100mcg Once Daily and Placebo in Symptomatic Pediatric Subjects (4-11 Years) With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate if once-daily dosing of ADVAIR 100/50 once-daily has superior efficacy and comparable safety compared with FP 100mcg once-daily in pediatric subjects 4 to 11 years of age with asthma.

Study identification

NCT ID
NCT00920959
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
908 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
4 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2001
Primary completion
Dec 31, 2003
Completion
Dec 31, 2003
Last update posted
Sep 14, 2016

2001 – 2004

United States locations

U.S. sites
141
U.S. states
35
U.S. cities
121
Facility City State ZIP Site status
GSK Investigational Site Ozark Alabama 36360
GSK Investigational Site Tucson Arizona 85716
GSK Investigational Site Tucson Arizona 85746
GSK Investigational Site Little Rock Arkansas 72205
GSK Investigational Site Beverly Hills California 90212
GSK Investigational Site Crescent City California 95531
GSK Investigational Site Dinuba California 93618
GSK Investigational Site Fresno California 93720
GSK Investigational Site Huntington Beach California 92647
GSK Investigational Site La Jolla California 92093
GSK Investigational Site Long Beach California 90806
GSK Investigational Site Mission Viejo California 92691
GSK Investigational Site Newport Beach California 92660
GSK Investigational Site Orange California 92868
GSK Investigational Site Palmdale California 93551
GSK Investigational Site Panorama City California 91402
GSK Investigational Site Paramount California 90723
GSK Investigational Site Riverside California 92506
GSK Investigational Site Rolling Hills Estates California 90274
GSK Investigational Site San Diego California 92120
GSK Investigational Site San Francisco California 94102
GSK Investigational Site San Jose California 95117
GSK Investigational Site Sherman Oaks California 91403
GSK Investigational Site Vista California 92083
GSK Investigational Site Vista California 92084
GSK Investigational Site Walnut Creek California 94598
GSK Investigational Site Centennial Colorado 80112
GSK Investigational Site Colorado Springs Colorado 80907
GSK Investigational Site Denver Colorado 80206
GSK Investigational Site Denver Colorado 80218
GSK Investigational Site Denver Colorado 80230
GSK Investigational Site Pueblo Colorado 81008
GSK Investigational Site Altamonte Springs Florida 32701
GSK Investigational Site Hialeah Florida 33013
GSK Investigational Site Jacksonville Florida 32216
GSK Investigational Site Orlando Florida 32801
GSK Investigational Site Orlando Florida 32806
GSK Investigational Site Sarasota Florida 34233
GSK Investigational Site St. Petersburg Florida 33710
GSK Investigational Site Tallahassee Florida 32308
GSK Investigational Site Tampa Florida 33613
GSK Investigational Site Atlanta Georgia 30309-7520
GSK Investigational Site Augusta Georgia 30901
GSK Investigational Site Barnesville Georgia 30204
GSK Investigational Site Martinez Georgia 30907
GSK Investigational Site Savannah Georgia 31406
GSK Investigational Site Chicago Illinois 60612
GSK Investigational Site Glenview Illinois 60025
GSK Investigational Site Hoffman Estates Illinois 60195
GSK Investigational Site Park Ridge Illinois 60068
GSK Investigational Site Indianapolis Indiana 46208
GSK Investigational Site South Bend Indiana 46617
GSK Investigational Site Lawrence Kansas 66047
GSK Investigational Site Louisville Kentucky 40222
GSK Investigational Site Murray Kentucky 42071
GSK Investigational Site Covington Louisiana 70433
GSK Investigational Site Metairie Louisiana 70001
GSK Investigational Site Metairie Louisiana 70006
GSK Investigational Site Shreveport Louisiana 71104
GSK Investigational Site Sunset Louisiana 70584
GSK Investigational Site Newton Massachusetts 02462
GSK Investigational Site North Dartmouth Massachusetts 02747
GSK Investigational Site Taunton Massachusetts 02780
GSK Investigational Site West Quincy Massachusetts 02169
GSK Investigational Site Detroit Michigan 48202
GSK Investigational Site Minneapolis Minnesota 55416
GSK Investigational Site Columbia Missouri 65212
GSK Investigational Site Kansas City Missouri 64108
GSK Investigational Site St Louis Missouri 63108
GSK Investigational Site St Louis Missouri 63139
GSK Investigational Site St Louis Missouri 63141
GSK Investigational Site Missoula Montana 59804
GSK Investigational Site Omaha Nebraska 68130
GSK Investigational Site Omaha Nebraska 68134
GSK Investigational Site Papillion Nebraska 68046
GSK Investigational Site Berlin New Jersey 08009
GSK Investigational Site Brick New Jersey 8724
GSK Investigational Site East Orange New Jersey 7017
GSK Investigational Site Ocean City New Jersey 07712
GSK Investigational Site Verona New Jersey 7044
GSK Investigational Site Albuquerque New Mexico 87131
GSK Investigational Site Buffalo New York 14222
GSK Investigational Site Liverpool New York 13088
GSK Investigational Site New Hyde Park New York 11042
GSK Investigational Site Rockville Centre New York 11570
GSK Investigational Site Vestal New York 13850
GSK Investigational Site Asheville North Carolina 28801
GSK Investigational Site Charlotte North Carolina 28204
GSK Investigational Site Durham North Carolina 27704
GSK Investigational Site Elizabeth City North Carolina 27909
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Canton Ohio 44718
GSK Investigational Site Cincinnati Ohio 45231
GSK Investigational Site Cleveland Ohio 44106
GSK Investigational Site Oklahoma City Oklahoma 73112
GSK Investigational Site Oklahoma City Oklahoma 73120
GSK Investigational Site Bend Oregon 97701
GSK Investigational Site Medford Oregon 97504
GSK Investigational Site Portland Oregon 97213
GSK Investigational Site Portland Oregon 97223
GSK Investigational Site Altoona Pennsylvania 16601
GSK Investigational Site Blue Belle Pennsylvania 19422
GSK Investigational Site Harrisburg Pennsylvania 17110
GSK Investigational Site Lewisburg Pennsylvania 17837
GSK Investigational Site Philadelphia Pennsylvania 19135
GSK Investigational Site Pittsburgh Pennsylvania 15202
GSK Investigational Site Pittsburgh Pennsylvania 15241
GSK Investigational Site Upland Pennsylvania 19013
GSK Investigational Site Lincoln Rhode Island 02865-4208
GSK Investigational Site Charleston South Carolina 29407
GSK Investigational Site Greenville South Carolina 29607
GSK Investigational Site Mt. Pleasant South Carolina 29464
GSK Investigational Site Spartanburg South Carolina 29303
GSK Investigational Site Knoxville Tennessee 37916
GSK Investigational Site Knoxville Tennessee 37917
GSK Investigational Site Knoxville Tennessee 37922
GSK Investigational Site Austin Texas 78749
GSK Investigational Site Dallas Texas 75230
GSK Investigational Site El Paso Texas 79902
GSK Investigational Site El Paso Texas 79925
GSK Investigational Site Galveston Texas 77555-0188
GSK Investigational Site Houston Texas 77054
GSK Investigational Site Houston Texas 77065
GSK Investigational Site Houston Texas 77074
GSK Investigational Site Lake Jackson Texas 77566
GSK Investigational Site New Braunfels Texas 78130
GSK Investigational Site Plano Texas 75093
GSK Investigational Site San Antonio Texas 78205
GSK Investigational Site San Antonio Texas 78207
GSK Investigational Site San Antonio Texas 78233
GSK Investigational Site Layton Utah 84041
GSK Investigational Site Murray Utah 84107
GSK Investigational Site Burke Virginia 22015
GSK Investigational Site Norfolk Virginia 23510
GSK Investigational Site Richmond Virginia 23229
GSK Investigational Site Richmond Virginia 23298
GSK Investigational Site Edmonds Washington 98026
GSK Investigational Site Tacoma Washington 98405
GSK Investigational Site Charleston West Virginia 25301
GSK Investigational Site Greenfield Wisconsin 53228
GSK Investigational Site La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00920959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 14, 2016 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00920959 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →